Antiasthmatic new Japanese molecules: the pharmacological profile of tiaramide hydrochloride.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000032:analysis; D000707:Anaphylaxis / Q000188:drug therapy; D000818:Animals; D001249:Asthma / Q000188:drug therapy; D052160:Benzothiazoles; D001980:Bronchi / Q000187:drug effects*; D001993:Bronchodilator Agents; D006168:Guinea Pigs; D006636:Histamine Release / Q000187:drug effects; D008297:Male; D008407:Mast Cells / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009712:Nucleotides, Cyclic / Q000032:analysis; D010879:Piperazines / Q000494:pharmacology*; D011451:Prostaglandin-Endoperoxide Synthases / Q000032:analysis; D051381:Rats; D014132:Trachea / Q000032:analysis / Q000187:drug effects*
D052160:Benzothiazoles; D001993:Bronchodilator Agents; D009712:Nucleotides, Cyclic; D010879:Piperazines; C003468:tiaramide; D011451:Prostaglandin-Endoperoxide Synthases; D015105:3',5'-Cyclic-AMP Phosphodiesterases